X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NIH Guide: SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS

SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS 

NIH GUIDE, Volume 21, Number 4, January 31, 1992

 

RFP AVAILABLE:  NICHD-CD-92-09

 

P.T. 34



Keywords:

  Chemical Synthesis 

  Biometry 

  Contraceptives 

 

National Institute of Child Health and Human Development

 

The Contraceptive Development Branch of the Center for Population

Research, National Institute of Child Health and Human Development, has

a requirement for the synthesis and testing of male contraceptive

agents.  The specific objectives of the project are the design,

synthesis, and testing of male contraceptive agents that inhibit

testicular sperm development, post-testicular sperm maturation, and

epididymal function.

 

Organizations must have adequate facilities and capabilities to carry

out the proposed synthetic chemical capabilities to carry out the

proposed synthetic chemical program.  Specifically excluded from this

project are LHRH analogs, gossypol derivatives, sex steroids, cytotoxic

agents, and all alkylating agents including chlorohydrin,

deoxyhalosugars, nitrogen mustards, ethyleneimines, and

sulfonoxyalkanes.  Non-specific antimetabolites, antimitotic agents, N-

Substituted diamines (such as WIN. 13,099), most major classes of

antibiotics, including the macrolides, aminoglycosides, penicillins,

tetracyclines, sulfasalazine, and co-trimoxazole, and nitroheterocyclic

compounds are also excluded.  Proposals to merely collect compounds

from various sources and/or only perform biological assays will not be

considered.

 

It is anticipated that four contract awards will be made for a maximum

period of three years each.

 

This announcement is not a Request for Proposals (RFP).  The RFP will

be issued on or about February 3, 1992.  Proposals will be due

approximately 90 days thereafter.  Requests for copies of the RFP may

be directed to:

 

Paul J. Duska, Contracting Officer

Contracts Management Branch, OGC

National Institute of Child Health and Human Development

Executive Plaza North, Room 610

900 Rockville Pike

Bethesda, MD  20892

FAX:  (301) 402-0915

 

.


Return to 1992 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.